362 related articles for article (PubMed ID: 15857927)
1. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K
Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927
[TBL] [Abstract][Full Text] [Related]
2. The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K
FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556
[TBL] [Abstract][Full Text] [Related]
3. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
4. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
5. Complement component C1q modulates the phagocytosis of Abeta by microglia.
Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a role for lactadherin in Alzheimer's disease.
Boddaert J; Kinugawa K; Lambert JC; Boukhtouche F; Zoll J; Merval R; Blanc-Brude O; Mann D; Berr C; Vilar J; Garabedian B; Journiac N; Charue D; Silvestre JS; Duyckaerts C; Amouyel P; Mariani J; Tedgui A; Mallat Z
Am J Pathol; 2007 Mar; 170(3):921-9. PubMed ID: 17322377
[TBL] [Abstract][Full Text] [Related]
7. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
8. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
[TBL] [Abstract][Full Text] [Related]
9. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.
Cui Y; Le Y; Yazawa H; Gong W; Wang JM
J Leukoc Biol; 2002 Oct; 72(4):628-35. PubMed ID: 12377930
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures.
Lotz M; Ebert S; Esselmann H; Iliev AI; Prinz M; Wiazewicz N; Wiltfang J; Gerber J; Nau R
J Neurochem; 2005 Jul; 94(2):289-98. PubMed ID: 15998280
[TBL] [Abstract][Full Text] [Related]
11. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
[TBL] [Abstract][Full Text] [Related]
13. Blockade of chloride intracellular ion channel 1 stimulates Abeta phagocytosis.
Paradisi S; Matteucci A; Fabrizi C; Denti MA; Abeti R; Breit SN; Malchiodi-Albedi F; Mazzanti M
J Neurosci Res; 2008 Aug; 86(11):2488-98. PubMed ID: 18438938
[TBL] [Abstract][Full Text] [Related]
14. TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation.
Liu S; Liu Y; Hao W; Wolf L; Kiliaan AJ; Penke B; Rübe CE; Walter J; Heneka MT; Hartmann T; Menger MD; Fassbender K
J Immunol; 2012 Feb; 188(3):1098-107. PubMed ID: 22198949
[TBL] [Abstract][Full Text] [Related]
15. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.
El Khoury J; Toft M; Hickman SE; Means TK; Terada K; Geula C; Luster AD
Nat Med; 2007 Apr; 13(4):432-8. PubMed ID: 17351623
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
17. The role and therapeutic potential of monocytic cells in Alzheimer's disease.
Malm T; Koistinaho M; Muona A; Magga J; Koistinaho J
Glia; 2010 Jun; 58(8):889-900. PubMed ID: 20155817
[TBL] [Abstract][Full Text] [Related]
18. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.
Takata K; Kitamura Y; Yanagisawa D; Morikawa S; Morita M; Inubushi T; Tsuchiya D; Chishiro S; Saeki M; Taniguchi T; Shimohama S; Tooyama I
FEBS Lett; 2007 Feb; 581(3):475-8. PubMed ID: 17240371
[TBL] [Abstract][Full Text] [Related]
19. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
Okura Y; Kohyama K; Park IK; Matsumoto Y
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
[TBL] [Abstract][Full Text] [Related]
20. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]